BEGIN:VCALENDAR VERSION:2.0 PRODID:-//The BioCalendar - ECPv6.15.20//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-ORIGINAL-URL:https://thebiocalendar.com X-WR-CALDESC:Events for The BioCalendar REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/Los_Angeles BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20250309T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20251102T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20260308T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20261101T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20270314T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20271107T090000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20250309T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20251102T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20260308T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20261101T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20270314T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20271107T060000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;VALUE=DATE:20260119 DTEND;VALUE=DATE:20260123 DTSTAMP:20260504T153127 CREATED:20251009T202757Z LAST-MODIFIED:20251029T141120Z UID:9262-1768780800-1769126399@thebiocalendar.com SUMMARY:PepTalk 2026 DESCRIPTION:Celebrate 25 Years of Innovation at PepTalk \nJoin a vibrant community of scientists\, trailblazers\, and industry leaders at PepTalk 2026\, as we mark 25 years of accelerating breakthroughs in biotherapeutic discovery and development. Renowned as one of the most influential events in protein science\, PepTalk is where fresh ideas ignite\, collaborations flourish\, and next-generation solutions take shape. \nThis year’s expanded agenda features symposia and conference tracks\, covering protein expression\, production platforms\, lab automation for higher throughput\, analytical characterization and preformulation strategies for novel modalities\, antibody discovery and development\, and new this year – expression and development of therapeutic peptides and miniproteins. \nGain insights from expert speakers\, engage with a dedicated community\, and leave with tools and strategies to move your research forward. \nExperience four days of focused learning\, expert-led sessions\, poster presentations\, keynotes\, roundtables\, panel discussions\, exhibitions\, and networking opportunities. URL:https://thebiocalendar.com/event/peptalk-2026/ LOCATION:San Diego\, San Diego\, CA\, United States CATEGORIES:Expo,Featured,Networking,Summit ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/10/pt26.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260120T110000 DTEND;TZID=America/Los_Angeles:20260120T120000 DTSTAMP:20260504T153127 CREATED:20260107T114118Z LAST-MODIFIED:20260107T131115Z UID:9730-1768906800-1768910400@thebiocalendar.com SUMMARY:Protecting Bioprocessing Operations And Supply Chains In A Turbulent Economy DESCRIPTION:Resilience is critical in biomanufacturing\, especially in an increasingly connected global ecosystem where economic shifts in one region can threaten operations everywhere. Join Bioprocess Online’s chief editor\, Tyler Menichiello\, for an interactive panel discussion on how companies are navigating a tight funding environment\, raw material shortages\, and global market pressures. The panel will feature Adam Golin\, a senior director of manufacturing at Sanofi; Jon Lindbloom\, the director of technical operations at Vaxart; and veteran industry leader James Sapirstein. \nExplore the ways inflation\, energy costs\, and supply chain disruptions are reshaping operations and learn what biotech companies can do to stay resilient during times of economic turbulence. URL:https://thebiocalendar.com/event/protecting-bioprocessing-operations-and-supply-chains-in-a-turbulent-economy-2/ LOCATION:CA ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/01-20-26-BPOL-LinkedIn-1280x720-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260121T110000 DTEND;TZID=America/Los_Angeles:20260121T120000 DTSTAMP:20260504T153127 CREATED:20260102T143634Z LAST-MODIFIED:20260102T143634Z UID:9702-1768993200-1768996800@thebiocalendar.com SUMMARY:Advancements In Targeted LNP Therapy (Free Live Event) DESCRIPTION:We’re still striving to deliver mRNA-LNPs to cells/tissue types that go beyond the liver. Outside of exploring different lipid combinations to expand mRNA-LNPs’ deliverability to new tissues\, this discussion will investigate the industry’s push toward active delivery to improve targeting\, as well as other advancements being made to improve LNP development\, quality\, & deliverability. \nRegistration is free thanks to the generous support from Cytiva! URL:https://thebiocalendar.com/event/advancements-in-targeted-lnp-therapy-free-live-event/ LOCATION:CA ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/01-21-26-ARNA-NL-468x60-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20260121T110000 DTEND;TZID=America/New_York:20260121T133000 DTSTAMP:20260504T153127 CREATED:20251216T171357Z LAST-MODIFIED:20251216T171357Z UID:9650-1768993200-1769002200@thebiocalendar.com SUMMARY:BVS' Biotech Community Celebration at Tech Square\, Cambridge DESCRIPTION:We are very excited to announce our indoor Biotech Community Lunch Event at the Atrium. \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \nAll the biotech tenants at 100-700 Technology Square and other companies in the Cambridge vicinity are invited to attend this event. \n✨ What to Expect: \n Vendor Exhibits: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\n Networking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\n Delicious Lunch: Enjoy a delicious lunch as you network and explore the vendor exhibits. \nWe welcome the entire Cambridge Biotech Community to join us for this exciting event! This is a wonderful chance for everyone to come together\, share insights\, and celebrate the vibrant biotech landscape in our region. \nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions etc.) from life science companies and research institutes. \n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there! URL:https://thebiocalendar.com/event/bvs-biotech-community-celebration-at-tech-square-cambridge-3/ LOCATION:CA ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2025/12/BVS-Biotech-Event-Flyer-01-21-26.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260122T110000 DTEND;TZID=America/Los_Angeles:20260122T120000 DTSTAMP:20260504T153127 CREATED:20251230T164151Z LAST-MODIFIED:20260102T132011Z UID:9691-1769079600-1769083200@thebiocalendar.com SUMMARY:Next-level cell lines: An integrated approach to biologic innovation DESCRIPTION:As artificial intelligence (AI) and digital tools rapidly evolve\, they are poised to reshape biopharmaceutical cell line development and subsequent manufacturing\, overcoming inefficiencies in expression\, scalability\, and production. \nThe webinar will discuss how the Cytiva™ cell culture media platform and Asimov’s CHO Edge system routinely deliver high-titer clones (8–11 g/L) in 14 weeks for monoclonal and multispecific antibodies. We will share a data-driven vision for the future of biologics production and discuss progress toward holistic optimal design of cell lines\, genetic systems\, and bioprocesses. URL:https://thebiocalendar.com/event/next-level-cell-lines-an-integrated-approach-to-biologic-innovation/ LOCATION:CA ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/12/1767109734168.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260122T110000 DTEND;TZID=America/Los_Angeles:20260122T120000 DTSTAMP:20260504T153127 CREATED:20260108T175609Z LAST-MODIFIED:20260108T175609Z UID:9752-1769079600-1769083200@thebiocalendar.com SUMMARY:2026 Regulatory Roadmap DESCRIPTION:Join Cell & Gene’s Chief Editor\, Erin Harris\, for this timely Cell & Gene Live offering an in-depth regulatory outlook with two of the field’s most trusted experts\, Wilson Bryan\, M.D.\, former director of FDA’s Office of Tissues and Advanced Therapies (OTAT)\, and Daniela Drago\, Ph.D.\, RAC\, Partner at NDA Partners. \nDrawing on his tenure leading the FDA’s OTAT\, Dr. Bryan will share a rare\, inside view of how regulators think about CGTs across CMC\, potency and comparability expectations\, and the next wave of guidances. Drago\, a global regulatory strategist who has led 100+ applications and secured orphan\, fast track\, breakthrough\, and RMAT designations across multiple modalities\, will translate those expectations into practical strategies for CGT sponsors as they design trials\, plan filings\, and position programs for global success. Together\, they will unpack the major regulatory developments CGT biotechs need to watch in 2026\, including evolving CMC rigor and clinical design for small populations to shifting global policies that will shape development\, approval\, and market access in the year ahead. This event will be a critically important hour for every role in the CGT value chain. See you there. Registration is free. URL:https://thebiocalendar.com/event/2026-regulatory-roadmap/ LOCATION:CA ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/01-22-25-CGL-LinkedIn-1280x720-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20260127T110000 DTEND;TZID=America/New_York:20260127T130000 DTSTAMP:20260504T153127 CREATED:20260106T133147Z LAST-MODIFIED:20260106T133544Z UID:9712-1769511600-1769518800@thebiocalendar.com SUMMARY:Outsourced Pharma Fill/Finish Capabilities Update (Free Virtual Event) DESCRIPTION:Hear directly from leading CDMOs about their current fill/finish capabilities\, facility locations\, and timelines. Through short\, interactive presentations\, you’ll gain insight into available capacity across sterile filling\, lyophilization\, and advanced packaging—all with the opportunity to ask live questions. URL:https://thebiocalendar.com/event/outsourced-pharma-fill-finish-capabilities-update/ LOCATION:CA ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/1-27-26-OPCU-230x90-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260128T110000 DTEND;TZID=America/Los_Angeles:20260128T120000 DTSTAMP:20260504T153127 CREATED:20251222T140524Z LAST-MODIFIED:20251222T140524Z UID:9668-1769598000-1769601600@thebiocalendar.com SUMMARY:(FREE) Simplified Harvest and Media Exchange in Cell Therapy: Consistent\, Compliant Scale-Up from Development to GMP DESCRIPTION:Developing robust cell harvest and media exchange processes is often complex\, particularly when moving from development to GMP manufacturing. Differences in equipment\, scale\, and automation can introduce variability and delay clinical timelines. Common methods such as TFF face challenges in maintaining consistent parameters during scale-up\, while disc-stack centrifugation lacks scale-down models and can expose cells to high shear\, reducing viability and product quality. Manual approaches\, though gentler\, increase variability and labor demands as processes scale. These issues complicate tech transfer\, process validation\, and regulatory alignment. \nThis webinar presents case studies demonstrating how a low-shear\, single-use centrifuge supports efficient harvest and media exchange for diverse cell types\, including iPSC aggregates and MSCs\, while preserving critical quality attributes (CQAs). The approach enables consistent process parameters and predictable performance from development through commercial manufacturing. By reducing engineering complexity and simplifying scale-up\, this technology helps shorten time-to-clinic. URL:https://thebiocalendar.com/event/free-simplified-harvest-and-media-exchange-in-cell-therapy-consistent-compliant-scale-up-from-development-to-gmp/ LOCATION:CA ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2025/12/01-28-26-CARR-eBlast-700x200-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260128T130000 DTEND;TZID=America/Los_Angeles:20260128T140000 DTSTAMP:20260504T153127 CREATED:20260106T125938Z LAST-MODIFIED:20260106T125938Z UID:9708-1769605200-1769608800@thebiocalendar.com SUMMARY:Embedding AI and Critical IRB Operations Data to Drive Intelligent Study Design DESCRIPTION:Study design is increasingly empowered by a rich and diverse array of data. New sources continue to emerge\, fueled by advances in AI that enable the integration of information from literature\, ClinicalTrials.gov\, digitized protocols\, and beyond. Harnessing these complementary data streams allows researchers to design studies that are not only operationally efficient but also more inclusive\, informed\, and scientifically sound. \nIn this webinar\, IDC analyst Dr. Nimita Limaye\, Research VP\, Life Sciences R&D\, Strategy and Technology\, joins Advarra’s Managing Director Ian Bailey for a dynamic discussion on how the industry can critically evaluate and integrate these data streams into their study design decisions. They will also investigate critical use cases\, analytical models\, and AI techniques that can transform these inputs into meaningful insights to optimize study design and maximize operational potential for pharma leaders. URL:https://thebiocalendar.com/event/embedding-ai-and-critical-irb-operations-data-to-drive-intelligent-study-design/ LOCATION:CA ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/01-28-26-Advarra-eBlast-700x200-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260129T110000 DTEND;TZID=America/Los_Angeles:20260129T120000 DTSTAMP:20260504T153127 CREATED:20260102T122031Z LAST-MODIFIED:20260102T122031Z UID:9695-1769684400-1769688000@thebiocalendar.com SUMMARY:Pharma 4.0 in Action: Building Digitally Connected Packaging Operations with Open Standards DESCRIPTION:This virtual event demonstrates how to bridge the gap between shopfloor operations (OT) and enterprise IT systems to achieve seamless machine integration\, real-time data flow\, and regulatory compliance. URL:https://thebiocalendar.com/event/pharma-4-0-in-action-building-digitally-connected-packaging-operations-with-open-standards/ LOCATION:CA ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/01-29-26-Koerber-Reg-1920x250-1.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260202 DTEND;VALUE=DATE:20260204 DTSTAMP:20260504T153127 CREATED:20251121T120044Z LAST-MODIFIED:20251121T120044Z UID:9562-1769990400-1770163199@thebiocalendar.com SUMMARY:Life Science Women's Conference 2026 DESCRIPTION:The Conference for Women Who Are Leading the Way in Life Science\nJoin us for two-days of networking with resourceful exhibitors\, presenters and speakers\, who are shaping what’s next in life science\, biotech\, medtech\,  femtech\, pharma\, women’s health and medicine. \nWith a focus on Funding & Entrepreneurship\, HR\, Career Development\, New Products\, and Career Connections\, the LSWC brings together some of the most successful professionals\, who want to connect with you! URL:https://thebiocalendar.com/event/life-science-womens-conference-2026/ LOCATION:Tampa Bay\, Tampa\, FL\, 33620\, United States CATEGORIES:Networking,Partnering,Women's Health END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260204T110000 DTEND;TZID=America/Los_Angeles:20260204T120000 DTSTAMP:20260504T153127 CREATED:20260107T153015Z LAST-MODIFIED:20260107T154103Z UID:9738-1770202800-1770206400@thebiocalendar.com SUMMARY:Injected\, Infused\, or Implanted: A Penetrating Look At Patient Centricity (Free Virtual Event) DESCRIPTION:Join Drug Delivery Leader’s Chief Editor Tom von Gunden as he engages drug delivery experts Beate Bittner\, Shannon Hoste\, Jonathan Amaya-Hodges\, and Fran DeGrazio in a discussion of innovations and advances in injectable\, infusible\, and implantable devices\, systems\, platforms\, and combinations. \nFocusing on unmet patient needs and expanded therapeutic targets\, the panel will discuss approaches and technologies that:\n– enable delivery outside of clinical settings\, including via at-home\, patient self-administration\n– expand the range of options for delivering complex biologics and other advanced therapies\n– leverage combination products or combined use systems for patient convenience and treatment efficacy\n– lessen the overall frequency and burden of treatment regimens \nCan’t watch the live discussion on February 4th? No problem! All registrants will receive an on-demand recording after the event. URL:https://thebiocalendar.com/event/injected-infused-or-implanted-a-penetrating-look-at-patient-centricity-free-virtual-event/ LOCATION:CA ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/26_02-DDL-HTML-600x300-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260204T110000 DTEND;TZID=America/Los_Angeles:20260204T120000 DTSTAMP:20260504T153127 CREATED:20260109T153939Z LAST-MODIFIED:20260109T153939Z UID:9757-1770202800-1770206400@thebiocalendar.com SUMMARY:Designing Drug Substance Processes for Fill-Finish Compatibility (Free Virtual Event) DESCRIPTION:Join KBI Biopharma and Argonaut Manufacturing Services for a candid fireside chat on breaking down silos between drug substance and drug product. Explore how an integrated\, quality-aligned approach can simplify execution and reduce timelines by 2–3 months from cell line development to drug product manufacturing. \nWhat you’ll learn:\n* How to overcome common CDMO and fill-finish integration challenges\n* Ways to reduce bottlenecks and avoid late-stage delays\n* Practical strategies to align quality\, regulatory\, and manufacturing processes end to end URL:https://thebiocalendar.com/event/designing-drug-substance-processes-for-fill-finish-compatibility-free-virtual-event/ LOCATION:CA ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/02-04-26-KBI-eblast-700x200-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260205T110000 DTEND;TZID=America/Los_Angeles:20260205T120000 DTSTAMP:20260504T153127 CREATED:20260107T153707Z LAST-MODIFIED:20260107T154206Z UID:9744-1770289200-1770292800@thebiocalendar.com SUMMARY:The Unfiltered Truth About CDMO Selection (Free Virtual Event) DESCRIPTION:Watch industry experts share practical guidance on how to evaluate CDMOs beyond the basics—focusing on experience\, talent\, and technologies that align with your development goals. \nSpeakers:\nJana Spes\, CEO & Co-founder\, JT Biopharma Partners\nPeter Bigelow\, CEO & Co-founder\, SCmple Solutions\nChristine Sheaffer\, Manufacturing & Supply Consultant\, Executive Leader Biotech Industry\nJeff Buguliskis\, PhD\, Chief Editor\, Outsourced Pharma \nCan’t watch the live discussion on February 5th? No problem! All registrants will receive an on-demand recording after the event. URL:https://thebiocalendar.com/event/the-unfiltered-truth-about-cdmo-selection-free-virtual-event/ LOCATION:CA ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/26_02-OPL-HTML-600x300-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260205T110000 DTEND;TZID=America/Los_Angeles:20260205T120000 DTSTAMP:20260504T153127 CREATED:20260109T183224Z LAST-MODIFIED:20260109T183224Z UID:9771-1770289200-1770292800@thebiocalendar.com SUMMARY:Selecting a Prefillable Syringe System with Confidence (Free Virtual Discussion) DESCRIPTION:Join West Pharmaceutical Services for a discussion on how to simplify the complex process of selecting a prefillable syringe system. With combination product requirements and ambiguous regulations\, traditional evaluation and testing can slow development and delay clinical timelines. \nThis presentation introduces the West Synchrony™ S1 Prefillable Syringe System—a fully integrated\, verified solution combining the barrel\, plunger\, and needle shield/tip cap from a single supplier. Discover how this harmonized system helps emerging biotech teams reduce risk\, save time and resources\, and accelerate the path to clinical fill. \nWhat you’ll learn:\n* What the West Synchrony™ S1 system is\n* How it streamlines development and supports faster submissions\n* How it reduces cost\, complexity\, and supply chain risk URL:https://thebiocalendar.com/event/selecting-a-prefillable-syringe-system-with-confidence-free-virtual-discussion/ LOCATION:CA ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/02-05-26-West-eBlast-700x200-1.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260207 DTEND;VALUE=DATE:20260213 DTSTAMP:20260504T153127 CREATED:20251125T141612Z LAST-MODIFIED:20251125T141612Z UID:9575-1770422400-1770940799@thebiocalendar.com SUMMARY:SLAS2026 International Conference & Exhibition DESCRIPTION:The SLAS International Conference and Exhibition is the flagship annual conference and exhibition presented by SLAS and the must-attend event dedicated to life sciences discovery and laboratory automation technology.  \nSchedule\nFebruary 7-8: Pre-conference Short Courses and Technology Provider Showcase\nFebruary 9-11: Dynamic Exhibition and Eight Scientific Tracks\nFebruary 12: NEW! Thrive in Science: SLAS Women’s Leadership Forum \nAttendance in 2025: 7500+ life sciences researchers and laboratory automation technology professionals under one roof! \nFeatures\nExhibition: SLAS2026 delivers a fast-paced exhibition experience\, including opportunities for business-to-business and business-to-consumer interactions. Attendees will see the latest products and services\, supplies and suppliers\, and have time to investigate automation solutions to drive new discoveries! \nEducation: Learn from experts across a broad spectrum of academia and industry\, sharing their life sciences research and the technological advances that enhance their success. Exhibitor tutorials and case studies\, NexusXp: The Connected Lab returns with panel discussions highlighting the DMTA cycle\, SLAS Topical Interest Group discussions and more. \nNetworking: Join discussions and interact with attendees at networking\, special interest and social events. \nRecognition: SLAS Travel Awards make it possible for podium and poster presenters to earn a free trip to SLAS2026. The SLAS Innovation Award honors the most innovative podium presentation and Student Poster Awards provide new scientists with the opportunity to present their research\, receive feedback and possibly win a $500 prize! URL:https://thebiocalendar.com/event/slas2026-international-conference-exhibition/ LOCATION:Boston\, MA\, 02210\, United States CATEGORIES:Expo,Networking,Symposium END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260209 DTEND;VALUE=DATE:20260213 DTSTAMP:20260504T153127 CREATED:20260106T192251Z LAST-MODIFIED:20260106T192251Z UID:9719-1770595200-1770940799@thebiocalendar.com SUMMARY:Advanced Therapies Week DESCRIPTION:Now in its 21st year\, Advanced Therapies Week is the premier biotech partnering event in the United States. Bringing together leaders in research\, therapeutic development\, and advanced manufacturing. \nJoin us at the Convention Center San Diego\, 09–12 February 2026 and get connected with the cell and gene therapy ecosystem. URL:https://thebiocalendar.com/event/advanced-therapies-week-2/ LOCATION:San Diego\, San Diego\, CA\, United States CATEGORIES:Partnering END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260210 DTEND;VALUE=DATE:20260213 DTSTAMP:20260504T153127 CREATED:20251212T172425Z LAST-MODIFIED:20260106T173034Z UID:9645-1770681600-1770940799@thebiocalendar.com SUMMARY:IO360° Summit DESCRIPTION:IO360° Delivers 4 Key Benefits\n  \n\n\n\n\n1.Delivering a 360° IO Community​ to Network and Form Collaborations\nBuild faster and more impactful collaborations with researchers\, clinicians\, biopharma leaders\, investors and policymakers to advance cancer treatments \n2. The Latest Data Driving Broader Impact\nHear directly from KOLs on the latest data to help advance and improve outcomes for more patients across a wider range of cancers\n​​​​​\n3. 360° Future-Focused Agenda\nStay ahead of the curve through 100+ multi-dimensional talks covering preclinical research\, translational science\, clinical development\, operational strategies\, cell therapy and business advancements \n4. 10+ Hours of Networking Opportunities\nMeet with key stakeholders in biopharma\, academia\, investors and regulatory through 1:1 meetings and scheduled functions \n\n15% Discount with Code BIG4BIO15 URL:https://thebiocalendar.com/event/io360-summit-2/ LOCATION:Boston\, MA\, 02210\, United States CATEGORIES:Summit END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260210T110000 DTEND;TZID=America/Los_Angeles:20260210T120000 DTSTAMP:20260504T153127 CREATED:20260113T134847Z LAST-MODIFIED:20260113T134847Z UID:9780-1770721200-1770724800@thebiocalendar.com SUMMARY:Charting the Path to First-In-Human: Strategic Readiness for Early Clinical Success DESCRIPTION:The road to first-in-human is one of the most pivotal—and complex—stages in drug development. It’s a journey that requires foresight\, coordination\, and a clear map connecting scientific innovation to operational execution. \nIn this live webinar\, experts from inSeption Group will outline proven strategies for navigating each phase of early clinical readiness and IND preparation. Learn how to anticipate challenges\, align cross-functional teams\, and build the operational “trail map” that ensures your program reaches its first patient efficiently and compliantly. URL:https://thebiocalendar.com/event/charting-the-path-to-first-in-human-strategic-readiness-for-early-clinical-success/ LOCATION:CA ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/02-10-26-ISG-eBlast-700x200-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260210T130000 DTEND;TZID=America/Los_Angeles:20260210T140000 DTSTAMP:20260504T153127 CREATED:20260115T190903Z LAST-MODIFIED:20260115T190903Z UID:9788-1770728400-1770732000@thebiocalendar.com SUMMARY:Bridging Discovery and CMC with Rapid Pools DESCRIPTION:The rapid growth of complex antibody modalities—including bispecifics\, multispecifics\, Fc-fusions\, and emerging formats—has widened the gap between discovery-stage expression systems and manufacturability. Transient expression\, still widely used for screening and optimization\, often fails to reveal architecture-driven liabilities such as chain imbalance\, mispairing\, instability\, aggregation\, or poor effective yield. As a result\, promising molecular formats may be prematurely deprioritized based on incomplete expression data\, or advanced with hidden risks that surface only during cell line development and CMC. \nAsimov’s Rapid Pools platform addresses this challenge by enabling high-throughput generation of stable CHO expression pools using a new high-efficiency transposase\, CHO-K1 GS host\, and model-guided vector design. By providing early\, CLD-relevant expression and assembly data\, RapidPools allow protein engineers to directly evaluate the manufacturability of complex architectures during the design phase. This enables informed sequence\, vector\, and chain-balancing optimizations that can derisk differentiated formats that might otherwise be dropped\, while more accurately identifying designs unlikely to scale. \nAttendees will learn how integrating stable expression readouts into protein engineering workflows improves predictability\, reduces late-stage risk\, and expands the viable design space for next-generation antibody therapeutics. URL:https://thebiocalendar.com/event/bridging-discovery-and-cmc-with-rapid-pools/ LOCATION:CA ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/Untitled-design-48.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260211T110000 DTEND;TZID=America/Los_Angeles:20260211T120000 DTSTAMP:20260504T153127 CREATED:20260109T181835Z LAST-MODIFIED:20260109T181835Z UID:9767-1770807600-1770811200@thebiocalendar.com SUMMARY:Optimizing Process Development Through Upstream And Downstream Integration DESCRIPTION:Join Bioprocess Online Chief Editor Tyler Menichiello on February 11\, at 11 a.m. Eastern\, for an interactive panel discussion exploring how upstream and downstream development teams can work together to reduce risk\, accelerate process scaling\, and support smoother downstream tech transfer. \nThe panel will feature Eric Doerr\, drug substance technical lead at Sanofi; Mark Fitchmun\, president and CEO of Somatek; Doug MacDonald\, the director of purification and process development at Immunome; Branden Salinas\, Ph.D.\, VP of process sciences at Umoja Biopharma; and Raj Prabu Vijayakumar Saraswathi\, Director of Biologics Process Development at RAPT Therapeutics. These leaders\, with collective experience across key modality types (e.g.\, mAbs\, ADCs\, and CGTs)\, will share their wisdom on the importance of coordination between upstream and downstream teams to avoid bottlenecks and mitigate failure. URL:https://thebiocalendar.com/event/optimizing-process-development-through-upstream-and-downstream-integration/ LOCATION:CA ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/26_02-BPOL-LinkedIn-1280x720-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260211T130000 DTEND;TZID=America/Los_Angeles:20260211T140000 DTSTAMP:20260504T153127 CREATED:20260211T175645Z LAST-MODIFIED:20260211T175645Z UID:9875-1770814800-1770818400@thebiocalendar.com SUMMARY:Outsourced Pharma Capabilities Update - Small Molecule Drug Product (Free Virtual Event) DESCRIPTION:Watch leading CDMOs share their current capabilities\, facility locations\, and timelines—helping you identify the right partners for your small molecule drug product development and manufacturing needs. \nWhat to expect:\n– Short digital presentations providing an inside look at supplier capacity\n– Live Q&A to ask questions and assess whether each CDMO can meet your needs\n– Convenient access from your computer—no travel required \nPlease note: This event is designed for biopharma companies seeking CDMO partners with capabilities that match their needs. URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-small-molecule-drug-product-free-virtual-event/ LOCATION:CA ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/Biocal-4.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260212T110000 DTEND;TZID=America/Los_Angeles:20260212T120000 DTSTAMP:20260504T153127 CREATED:20260211T180019Z LAST-MODIFIED:20260211T180019Z UID:9879-1770894000-1770897600@thebiocalendar.com SUMMARY:Outsourced Pharma Capabilities Update - Cell & Gene DESCRIPTION:Watch leading CDMOs share their current capabilities\, facility locations\, and timelines—helping you identify the right partners for your cell and gene development and manufacturing needs. \nExplore the fast-growing field of cell and gene therapy\, including:\n– Cell sourcing and expansion\n– Vector design and gene therapy delivery mechanisms\n– Formulation development and GMP-compliant processes ensuring patient safety and product quality \nWhat to expect:\n– Short digital presentations with live interaction providing an inside look at supplier capacity\n– Opportunity to ask questions and assess whether each CDMO can meet your needs\n– All accessible from your computer—no travel required \nPlease note: This event is designed for biopharma companies seeking CDMO partners with available capacity. URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-cell-gene/ LOCATION:CA ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/Biocal-6.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260217T080000 DTEND;TZID=America/Los_Angeles:20260217T113000 DTSTAMP:20260504T153127 CREATED:20251125T141905Z LAST-MODIFIED:20251125T141905Z UID:9576-1771315200-1771327800@thebiocalendar.com SUMMARY:Houston Life Sciences Commercial Real Estate Conference DESCRIPTION:Join us at the Houston Life Sciences Commercial Real Estate Conference\, where researchers\, developers\, investors\, and real estate professionals converge to examine the forces shaping one of the fastest-growing innovation hubs in the country. Houston’s world-class medical institutions\, biotech startups\, and research facilities are driving breakthroughs in healthcare\, pharmaceuticals\, and medical technology.  \nThis event will highlight how real estate development\, capital investment\, and cross-sector collaboration are fueling the growth of the city’s life sciences ecosystem. From building next-generation lab and manufacturing facilities to fostering partnerships between academia and industry\, attendees will gain valuable insights into the future of life sciences and its impact on commercial real estate. URL:https://thebiocalendar.com/event/houston-life-sciences-commercial-real-estate-conference/ LOCATION:Houston\, Houston\, TX\, 77001\, United States CATEGORIES:Forum END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260217T110000 DTEND;TZID=America/Los_Angeles:20260217T130000 DTSTAMP:20260504T153127 CREATED:20260121T135208Z LAST-MODIFIED:20260121T135349Z UID:9802-1771326000-1771333200@thebiocalendar.com SUMMARY:Outsourced Pharma Capabilities Update: AI Drug Development (Free Virtual Event) DESCRIPTION:In this Capabilities Update\, industry leaders will share where AI is delivering value today—from hit-to-lead optimization and analytical method development to model-informed process development and digital CPV/QMS—and how CDMOs and sponsors can collaborate to reduce cycle times\, improve quality\, and de-risk scale-up. \nAttendees will gain a practical CDMO readiness checklist and insights into sponsor expectations for the next 12 months\, along with real-world guidance on integrating AI into route scouting\, tech transfer\, scale-up\, batch release\, and quality decision-making. URL:https://thebiocalendar.com/event/outsourced-pharma-capabilities-update-ai-drug-development-free-virtual-event/ LOCATION:CA ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/Biocal.png END:VEVENT BEGIN:VEVENT DTSTART;VALUE=DATE:20260218 DTEND;VALUE=DATE:20260220 DTSTAMP:20260504T153127 CREATED:20260116T120621Z LAST-MODIFIED:20260116T120621Z UID:9792-1771372800-1771545599@thebiocalendar.com SUMMARY:SapioCon 2026 DESCRIPTION:2026 marks a turning point in life sciences — the year AI moves from concept to core capability. With ELaiN\, the world’s first AI-native ELN\, Sapio is leading this transformation\, making software simple to use and empowering labs to think faster and innovate smarter. \nThis is your chance to connect with industry leaders\, network with peers\, and talk with Sapio experts. \nBe there to experience firsthand how AI is redefining biopharma R&D and diagnostics\, connect with peers at the forefront of change\, and see what’s next in the journey toward smarter science. \nBoston is the stage. ELaiN is the catalyst. You are the future. By the end of SapioCon\, you’ll walk away with: \n\nA clearer vision for applying AI and automation in science\nPractical strategies from real customer experiences\nNew technical skills and product knowledge\nConnections that expand your professional network and impact\n\n\n\nWhat to Expect at SapioCon 2026: \n\nCustomer Stories: Real Results\, Real Impact\nLearn how peers overcame challenges similar to yours\nAI Keynotes: The Future of Science\, Now!\nUnderstand how AI can free researchers from repetitive tasks\, accelerate discovery\, and amplify human insight — with practical examples you can bring back to your lab\nExciting Product Reveals\nGet to know what’s new and what’s coming soon.\nSolution Presentations: Explore What’s Possible\nLearn how to streamline scientific data\, automate workflows\, and increase productivity across your organization\nTech Talks: Behind the Innovation\nGiving you actionable tools for implementation\nShort Courses: Hands-On Learning\nBuild your practical skills\nand much more … URL:https://thebiocalendar.com/event/sapiocon-2026/ LOCATION:Boston\, MA\, 02210\, United States CATEGORIES:Summit END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260218T080000 DTEND;TZID=America/Los_Angeles:20260218T170000 DTSTAMP:20260504T153127 CREATED:20260218T162115Z LAST-MODIFIED:20260218T162115Z UID:9918-1771401600-1771434000@thebiocalendar.com SUMMARY:How AI-Enabled Digital Validation Technologies Enable the Predictive Plant DESCRIPTION:As life sciences manufacturers progress along their digital maturity journey\, validation data is increasingly recognized as a strategic asset rather than a compliance artifact. In this session\, experts will illustrate how digitally mature organizations leverage Digital Validation Technologies (DVTs) as a core component of their broader digital ecosystem. Attendees will gain a clear understanding of how AI-enabled digital validation accelerates the move from compliance-driven validation to predictive asset intelligence—supporting scalable manufacturing\, resilient operations\, and sustained readiness for future regulatory and business demands. \nSecond-generation\, AI-enabled Digital Validation Technologies (DVTs) URL:https://thebiocalendar.com/event/how-ai-enabled-digital-validation-technologies-enable-the-predictive-plant/ LOCATION:CA ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/03-18-26-CAI-LinkedIn-1280x720-v1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260218T110000 DTEND;TZID=America/Los_Angeles:20260218T120000 DTSTAMP:20260504T153127 CREATED:20260107T182155Z LAST-MODIFIED:20260107T182155Z UID:9748-1771412400-1771416000@thebiocalendar.com SUMMARY:Four Common Pitfalls to Avoid in UF/DF Setup and Scale-Up DESCRIPTION:Ultrafiltration/Diafiltration (UF/DF) processes that look robust at the development scale often expose critical weaknesses during scale-up or tech transfer—resulting in capacity constraints\, excessive manual intervention\, delayed timelines\, or manufacturing risk. In many cases\, these issues trace back to early UF/DF decisions that seemed reasonable at the time but didn’t fully account for scalability\, system design\, or cross-functional alignment. \nIn this webinar\, we’ll break down four of the most common—and costly—pitfalls in UF/DF setup and scale-up\, including poor filter sizing and membrane selection\, overreliance on manual operations\, system design limitations\, and breakdowns in communication between Process Development and MSAT teams. Through practical examples drawn from downstream workflows\, we’ll show how these pitfalls emerge\, why they persist\, and how they impact process robustness and manufacturing success. \nAttendees will leave with practical strategies to design more scalable UF/DF processes\, reduce manual burden\, improve system selection\, and strengthen PD–MSAT collaboration—helping teams avoid late-stage surprises and enabling smoother tech transfer to manufacturing. \n ~ Avoid scale-up surprises with membrane selection strategies that are fit-for-purpose\n ~Reduce manual burden and operational risk by understanding when automation and system design choices matter most for robust\, scalable UF/DF operations\n ~Enable smoother tech transfer by improving alignment and communication between Process Development and MSAT teams early in process design URL:https://thebiocalendar.com/event/four-common-pitfalls-to-avoid-in-uf-df-setup-and-scale-up/ LOCATION:CA ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/01/02-18-26-Repligen-LinkedIn-1280x720-1.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260218T130000 DTEND;TZID=America/Los_Angeles:20260218T140000 DTSTAMP:20260504T153127 CREATED:20260211T190213Z LAST-MODIFIED:20260211T190213Z UID:9891-1771419600-1771423200@thebiocalendar.com SUMMARY:AI In Clinical Trials: What's New & What's Hype? DESCRIPTION:Back By Popular Demand!\nOur third Clinical Leader Live on AI will go beyond the buzzwords to focus on what’s actually working in clinical operations. \nYou will hear about some of the newest real-world applications\, lessons learned from early adopters\, and how to spot hype before it costs you time or money. \nRegistration is free with thanks to our sponsors for this live event: Medable\, PPD Clinical Research Business of Thermo Fisher Scientific and AG Mednet. URL:https://thebiocalendar.com/event/ai-in-clinical-trials-whats-new-whats-hype/ LOCATION:CA ATTACH;FMTTYPE=image/png:https://thebiocalendar.com/wp-content/uploads/2026/02/26_02_CLL_468x60.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20260218T160000 DTEND;TZID=America/Los_Angeles:20260218T183000 DTSTAMP:20260504T153127 CREATED:20260127T155653Z LAST-MODIFIED:20260127T155653Z UID:9820-1771430400-1771439400@thebiocalendar.com SUMMARY:BVS and BioMed Realty's Biotech Community Event in SSF DESCRIPTION:Join Us for the BVS and BioMed Realty Biotech Community Event! \nMark your calendars for a great opportunity to connect with industry leaders\, explore innovative products\, and mingle with fellow professionals in the biotech community. \nThe vendor fair is held at The Forum\, in the same building as Amgen and next to Genentech\, right in the heart of the large pharma/biotechs in South San Francisco. \n✨ What to Expect: \n Vendor Exhibit: Discover a diverse range of exhibitors showcasing cutting-edge technology and services in the biotech space.\n Networking Opportunities: Engage with fellow industry experts\, forge new connections\, and exchange ideas that could shape the future of biotech.\n Appetizers & Drinks: Enjoy delicious refreshments as you network and explore the vendor exhibits. \nWe welcome the entire Bay Area Biotech Community to join us for this exciting event! This is a wonderful chance for everyone to come together\, share insights\, and celebrate the vibrant biotech landscape in our region. \nAdmission Details:\nFREE for life science job-related employees (including researchers\, scientists\, purchasing\, clinical\, manufacturing\, non-sales/bus dev positions etc.) from life science companies and research institutes.\n$200 fee for product and service providers who sell to the life science community (e.g. BVS suppliers\, business development/sales\, marketing\, lawyers\, consultants)\, which includes access to the event but does not include an exhibitor table. Exhibitor tables can be purchased separately. \nFor exhibitor tables\, please visit our website and register at: https://bvsconnection.com/events \nPlease feel free to invite others in the community that could benefit from attending. \nWe look forward to seeing you there! URL:https://thebiocalendar.com/event/bvs-and-biomed-realtys-biotech-community-event-in-ssf-6/ LOCATION:CA ATTACH;FMTTYPE=image/jpeg:https://thebiocalendar.com/wp-content/uploads/2026/01/Biotech-Event-Flyer-02-18-26-2250x4000px.jpg END:VEVENT END:VCALENDAR